WHO ICTRP trial
Comparison of three doses of tiotropium inhalation solution delivered via a…
EUCTR2010-018471-26-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-018471-26-DE |
|---|---|
| Public title | Comparison of three doses of tiotropium inhalation solution delivered via a device called Respimat® inhaler with the aim to evaluate the efficacy and the safety of tiotropium. Patients with moderate persistent asthma will receive each treatment for 4 weeks once daily: 1.25, 2.5, 5.0 microgram tiotropium and placebo. The sequence of the 4 treatments will be randomly assigned to the patients, and neither the patient nor the treating investigator knows when the patient gets which treatment. |
| Scientific title | A Phase II randomised, double-blind, placebo controlled, cross-over efficacy and safety comparison of three doses of tiotropium inhalation solution delivered via Respimat® inhaler (1.25, 2.5 and 5.0 µg once daily) versus placebo in patients with moderate persistent asthma. |
| Primary sponsor | Boehringer Ingelheim Pharma GmbH & Co. KG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Ukraine;Austria;Germany |
| Conditions | moderate persistent asthma MedDRA version: 14.0 Level: LLT Classification code 10003555 Term: Asthma bronchial System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory… |
| Interventions | Trade Name: Spiriva Respimat 2.5 microgram, solution for inhalation Product Name: Spiriva Respimat 2.5 mcg Product Code: Tiotropium Respimat Pharmaceutical Form: Inhalation vapour, solution Current Sponsor code: Ba 679 Br Other descriptive… |
| Registration date | Sep 8, 2010 |
| Target size | 120 |
| Secondary IDs | 205.380 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: